Citation Impact
Citing Papers
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
2020 Standout
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
2020 Science
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
2020 Standout
Microbiota in health and diseases
2022 Standout
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Emerging paradigms in GPCR allostery: implications for drug discovery
2013
Structure-based drug screening for G-protein-coupled receptors
2012 StandoutNobel
G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function
2009
Drugs acting on renin angiotensin system and use in ill patients with COVID-19
2020
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Signaling by Sensory Receptors
2011 StandoutNobel
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
2020
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Ulcerative colitis
2020 Standout
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
2020
The Use of GPCR Structures in Drug Design
2011
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
2014
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
2020 Standout
Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis
2017
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
2020
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection
2020
COVID-19 and Cardiovascular Disease
2020
The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
2019
COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
2020
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
2020 Standout
Role and mechanism of angiotensin‐converting enzyme 2 in acute lung injury in coronavirus disease 2019
2020
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of Tracey J. Wright being referenced
Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2
2008
Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury
2018
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
2017
Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial
2014
Specificity of human anti-variable heavy (VH) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1
2015